|
m Im/08 / Provecs Medical (0 Trials) |
m Im01 / Provecs Medical (0 Trials) |
M-001 / FairWinds Bio, Greenfire Bio (0 Trials) |
M-3258 / EMD Serono (0 Trials) |
M-400 / Debiopharm (0 Trials) |
m-ceNK cells / ImmunityBio (0 Trials) |
M-Vax (DNP VACC) / AVAX Technologies (0 Trials) |
M012 / Merganser (0 Trials) |
M032 / The University of Alabama (0 Trials) |
M102 / Aclipse Therap, The University of Sheffield (0 Trials) |
M106 / Aclipse Therap, The University of Sheffield (0 Trials) |
M1069 / EMD Serono, Domain Therap (0 Trials) |
M118103 / Maruho (0 Trials) |
M1231 / EMD Serono (0 Trials) |
M1E4 / Stainwei Biotech (0 Trials) |
M201-A / AETAS Pharma (0 Trials) |
M23 / Stainwei Biotech (0 Trials) |
M254 / J&J (0 Trials) |
M267 / J&J (0 Trials) |
M3541 / EMD Serono (0 Trials) |
M4112 / EMD Serono (0 Trials) |
M4205 / EMD Serono (0 Trials) |
M4645 / EMD Serono (0 Trials) |
M4K2009 / M4K Pharma (0 Trials) |
M4K2149 / M4K Pharma (0 Trials) |
M5250 / Maruho (0 Trials) |
M610 / National Cancer Center Hospital (0 Trials) |
M6123 / Ligand, EMD Serono (0 Trials) |
M701 / YZY Biopharma (0 Trials) |
M7583 / EMD Serono, Telios Pharma (1 Trials) |
M802 / YZY Biopharma (0 Trials) |
M834 (abatacept biosimilar) / Viatris (0 Trials) |
M9140 / EMD Serono (0 Trials) |
M923 (adalimumab biosimilar) / J&J (0 Trials) |
M9466 / EMD Serono (0 Trials) |
M9657 / EMD Serono (0 Trials) |
M9831 / EMD Serono (0 Trials) |
MA-005 / Hofseth Biocare (0 Trials) |
MA2-014 / Aptose Biosci (0 Trials) |
Maalox (aluminum hydroxide/simethicone/magnesium hydroxide) / Sanofi (1 Trials) |
MaaT013 / MaaT Pharma (0 Trials) |
MaaT033 / MaaT Pharma (0 Trials) |
MaaT034 / MaaT Pharma (0 Trials) |
Maball (rituximab biosimilar) / Hetero (1 Trials) |
mAbCo19 / AchilleS Vaccines (0 Trials) |
MabionCD20 (rituximab biosimilar) / HB Human BioSci, Mabion (1 Trials) |
MabionHER2 (trastuzumab biosimilar) / Mabion (0 Trials) |
Mabtas (rituximab biosimilar) / Intas (22 Trials) |
Mabura (adalimumab biosimilar) / Hetero (0 Trials) |
Mabvinra (adalimumab biosimilar) / Alkem Labs (0 Trials) |
mAbx01 (etanercept biosimilar) / Grupo Insud (0 Trials) |
MACI (matrix-induced autologous chondrocyte implant) / Vericel (1 Trials) |
macozinone (PBTZ169) / Innovative Medicines for Tuberculosis, Nearmedic, Bill & Melinda Gates Foundation (0 Trials) |
Macrilen (macimorelin) / AEterna Zentaris (2 Trials) |
Macroazi (azithromycin) / Orchid (0 Trials) |
macrocyclic peptide / Merck (MSD) (0 Trials) |
macrolide analogs / Melinta Therap (0 Trials) |
Macugen (pegaptanib) / Bausch Health (10 Trials) |
Macuneos (BIO-201) / Biophytis (0 Trials) |
MAD-bisphosphonate therapy / Navidea (0 Trials) |
MAD-paclitaxel therapy / Navidea (0 Trials) |
MAD0004J08 / Toscana Life Sci (0 Trials) |
mafenide / Generic mfg. (0 Trials) |
MAG200 / Magellan Biologicals (0 Trials) |
MAGE A3 TCR / Gilead, National Cancer Institute (0 Trials) |
MageA1-TCR Gene Therapy of Multiple Myeloma / Medigene, Max Delbrück Centre for Molecular Medicine, Charite - University of Medicine Berlin (0 Trials) |
Magicell-NK / Medigen Biotech (0 Trials) |
Magna Effervescent (magnesium oxide+sodium carbonate+sodium bicarbonate+citric acid+saccharin sodium) / SEDICO (0 Trials) |
magnesium L-lactate dehydrate (MLD10) / Pharmalyte Solutions (0 Trials) |
magnesium trisilicate/dried aluminium hydroxide / Generic mfg. (0 Trials) |
MagneVal (valproate magnesium) / BioLink Life Sci (0 Trials) |
magrolimab (GS-4721) / Ono Pharma (16 Trials) |
MAHDL01 / World Health Energy, Mazal Plant Pharma (0 Trials) |
MAIA-2021-20 / MAIA Biotech (0 Trials) |
MAIA-2022-12 / MAIA Biotech (0 Trials) |
Mailishu (denosumab biosimilar) / Mabwell (Shanghai) Biosci, Binnopharm (0 Trials) |
MAK11049 / MAKScientific (0 Trials) |
MAK1400 / Biogen (0 Trials) |
MAK683 / Novartis (1 Trials) |
MAL oral / D&A Pharma (0 Trials) |
malaria vaccine / Sanofi (0 Trials) |
malaria vaccine / Protein Potential, Novartis (0 Trials) |
malaria vaccine (Px533) / Ligand (0 Trials) |
MALT1 protein inhibitor / Medivir (0 Trials) |
MAM01 / Atreca, Bill & Melinda Gates Foundation (0 Trials) |
Mambisa (CIGB-669) / Center for Genetic Engineering and Biotechnology (0 Trials) |
mammaglobin-A DNA vaccine / Washington University School of Medicine in St. Louis (0 Trials) |
MAN-01 / Mannin Research, Q BioMed (0 Trials) |
MAN-02 / Mannin Research, Q BioMed (0 Trials) |
MAN-03 / Mannin Research, Q BioMed (0 Trials) |
MAN-04 / Mannin Research, Q BioMed (0 Trials) |
MAN-19 / Mannin Research, Q BioMed (0 Trials) |
MANA-312 / MANA Therap (0 Trials) |
MANA-412 / MANA Therap (0 Trials) |
manelimab (BCD-135) / Biocad (0 Trials) |
MANF / Healixa (0 Trials) |
manfidokimab (AK120) / Akesobio (0 Trials) |
ManNAc / Fortress, Leadiant Biosci (0 Trials) |
mannoside FimH antagonist / Fimbrion Therap (0 Trials) |
manocept-doxorubicin / Navidea (0 Trials) |
MAP-Tau based therapeutic / PTC Therap (0 Trials) |
mapatumumab (HGS-ETR1) / GSK (0 Trials) |
MAPK pathway therapeutic / Jazz, Redx (0 Trials) |
maplirpacept (TTI-622) / Pfizer (0 Trials) |
mapracorat (BOL-303242-X) / Bayer (0 Trials) |
maprotiline / Generic mfg. (1 Trials) |
MAR701 / Roche (0 Trials) |
Marabex (MAGE-A3 vaccine) / Turnstone Biologics, AbbVie (0 Trials) |
maranmicin (ABX-605) / AGileBiotics (0 Trials) |
Margenza (margetuximab) / MacroGenics, ZAI Lab (3 Trials) |
maridebart cafraglutide (AMG 133) / Amgen (0 Trials) |
Marinus / Aphios (0 Trials) |
Marizev (omarigliptin) / Merck (MSD) (0 Trials) |
marizomib (NPI-0052) / Triphase Accelerator Corporation, BMS (3 Trials) |
Marplan (isocarboxazid) / Validus (0 Trials) |
Marqibo (vincristine liposomal) / Servier, Aurobindo (7 Trials) |
marrow infiltrating lymphocytes / WindMIL Therap (0 Trials) |
marstacimab (PF-06741086) / Pfizer (2 Trials) |
marzeptacog alfa (CB 813d) / GC Biopharma (0 Trials) |
Marzulene-S Combination Granules / Kotobuki (0 Trials) |
MAS825 / Novartis (0 Trials) |
MASCT-I / HRYZ BIOTECH (1 Trials) |
masilukast (MCC-847) / Mitsubishi Tanabe (0 Trials) |
masked antibody drug conjugate therapeutic / Adagene, Mitsubishi Tanabe (0 Trials) |
masofaniten (EPI-7386) / ESSA Pharma (0 Trials) |
masoprocol (TT-100) / TriAct Therap (0 Trials) |
MASP-2 inhibitor therapeutic / Omeros (0 Trials) |
MASP-2/3 inhibitor therapeutic / Omeros (0 Trials) |
MASP-3 inhibitor therapeutic / Omeros (0 Trials) |
masupirdine (SUVN-502) / Suven Life Sci (2 Trials) |
Matulane (procarbazine hydrochloride) / Leadiant Biosci (16 Trials) |
matuzumab (EMD 72000) / Takeda, EMD Serono (0 Trials) |
MAU868 / Vera Therap (0 Trials) |
mavatrep (JNJ-39439335) / J&J (0 Trials) |
mavelertinib (PF-06747775) / Pfizer (0 Trials) |
Mavenclad (cladribine) / EMD Serono (29 Trials) |
maveropepimut-S (MVP-S) / BioVaxys (8 Trials) |
mavodelpar (REN001) / Reneo Pharma (1 Trials) |
mavoglurant (STP7) / STALICLA (5 Trials) |
mavorixafor (X4P-001) / X4 Pharma (5 Trials) |
mavrilimumab (KPL-301) / Kiniksa (3 Trials) |
MAVU-104 / AbbVie (0 Trials) |
Mavyret (glecaprevir/pibrentasvir) / AbbVie, Enanta Pharma (30 Trials) |
MAX-10129 / Maxinovel (0 Trials) |
Max-10181 / Maxinovel (0 Trials) |
Max-40279 / Maxinovel (3 Trials) |
MAX-5 / Maxinovel (0 Trials) |
MAX-6 / Maxinovel (0 Trials) |
MAX-7 / Maxinovel (0 Trials) |
Maxair autohaler (pirbuterol aerosol) / Bausch Health (0 Trials) |
Maxidex (dexamethasone eye drops, suspension) / Novartis (17 Trials) |
Maxido Plus (valsartan + hydrochlorothiazide) / Alvogen Korea (0 Trials) |
Maxigesic (acetaminophen/ibuprofen) / AFT Pharma, Hyloris Pharma, BioSyent, Hikma (0 Trials) |
Maxomat (somatropin) / Sanofi (0 Trials) |
Maxsulin (human insulin rDNA) / Incepta Pharma (0 Trials) |
Maxy-G34 / Maxygen (0 Trials) |
Mayzent (siponimod) / Novartis (8 Trials) |
mazdutide (LY3305677) / Eli Lilly (0 Trials) |
MazF gene therapy / Takara (0 Trials) |
mazindol controlled release (NLS-2) / NLS Pharma (0 Trials) |
MB-101 / Fortress (2 Trials) |
MB-101 / Macrobian-Biotech (0 Trials) |
MB-102 / Fortress (2 Trials) |
MB-103 / Fortress (0 Trials) |
MB-104 / Fortress (0 Trials) |
MB-105 / Fortress (0 Trials) |
MB-105 / March Bio (0 Trials) |
MB-106 / Fortress (0 Trials) |
MB-107 / Fortress (0 Trials) |
MB-108 / Fortress (0 Trials) |
MB-109 / Fortress (0 Trials) |
MB-110 / Microbio (1 Trials) |
MB-204 / Marvel Biosci (0 Trials) |
MB-6 / Microbio (0 Trials) |
MB-CAR-T19-22 / Miltenyi Biotec (0 Trials) |
MB-CART 19.1 / Miltenyi Biotec (0 Trials) |
MB-CART 2219.1 / Miltenyi Biotec (0 Trials) |
MB-CART20.1 / Miltenyi Biotec (0 Trials) |
MB-dNPM1-TCR.1 / Miltenyi Biotec (0 Trials) |
MB-X01Y03 / Protheragen (0 Trials) |
MB03 / Grupo Insud (0 Trials) |
MB04 / Grupo Insud (0 Trials) |
MB05 (palivizumab biosimilar) / Grupo Insud (0 Trials) |
MB07133 / Xi’an XinTong Pharma (2 Trials) |
MB09 (denosumab biosimilar) / Grupo Insud, Amneal, Korea Kolmar (0 Trials) |
MB097 / Microbiotica (0 Trials) |
MB11 / Grupo Insud (0 Trials) |
MB12 (pembrolizumab biosimilar) / Grupo Insud (0 Trials) |
MB13 / Grupo Insud (0 Trials) |
MB1707 / Mainline Biosci (0 Trials) |
MB310 / Microbiotica, Roche (0 Trials) |
MB66 / Mapp Biopharma (0 Trials) |
MBK-101 / Eli Lilly (0 Trials) |
MBK-102 / Eli Lilly (0 Trials) |
MBK-103 / Eli Lilly (0 Trials) |
MBL-HCV1 / MassBiologics (0 Trials) |
MBL949 / Novartis (0 Trials) |
MBNL protein expression enhancing antagomiR / University of Valencia (0 Trials) |
MBP87-99 / Burnet Institute (0 Trials) |
MBS2133 / Istesso (0 Trials) |
|